Showing results (31-40 of 89) with videos related to
Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2013
A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patientsCraig S Sauter, Juliet N Barker, Lauren Lechner, et al.Transplantation and Cellular Therapy|July 2, 2021
Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft RecipientsRoni Tamari, Samantha Brown, Sean M Devlin, et al.Journal of Hematology & Oncology|October 22, 2018
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCCFlorent Malard, Myriam Labopin, Christina Cho, et al.Leukemia & Lymphoma|February 10, 2022
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantationAndrew Lin, Samantha Brown, Molly Maloy, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Meier Hsu, Ann A Jakubowski, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantationDoris M Ponce, Craig Sauter, Sean Devlin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2018
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell TransplantationCarlos Rondon-Clavo, Michael Scordo, Patrick Hilden, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 8, 2013
Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remissionUlas D Bayraktar, Marcos de Lima, Rima M Saliba, et al.Blood Advances|March 29, 2019
Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysisJuliet N Barker, Kirsten Boughan, Parastoo B Dahi, et al.Leukemia & Lymphoma|December 6, 2011
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplantJenna D Goldberg, Joanne F Chou, Steven Horwitz, et al.Pageof 9